Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Drug Price Adjustment Range Must Be Reviewed: JMA
March 5, 2001
- JPMA Inaugurates 'Council on Planning & Policy'
March 5, 2001
- SSP Completely Acquires Nutrichem of Germany
March 5, 2001
- Korosho Asks Makers to Report Errors in Standard Product Code
March 5, 2001
- Roche CEO Expects Leadership from Mr Ogawa
March 5, 2001
- Nippon Shinyaku to Terminate Development of NS-49
March 5, 2001
- JPMA Compiles Report on Globalization
March 5, 2001
- Nippon Shinyaku, SSP to Codevelop Synthetic Steroid
March 5, 2001
- Drug Wholesaler Tie-ups, M&As in 2000
March 5, 2001
- Only 70% of Hospitals Hire No. of Drs Required by Law
March 5, 2001
- SAS Institute to Start New Portal Service for R&D
March 5, 2001
- COX2 Inhibitor Expected to Prevent NSAID-induced Ulcers: Pharmacia Forum
March 5, 2001
- METI Report Calls For Free Competition for Medical, Nursing Care Services
February 26, 2001
- BUSINESS NEWS IN BRIEF -1-
February 26, 2001
- Elimination of NHI Price SystemShould Be Considered: Prof. Tokita
February 26, 2001
- REGULATORY NEWS IN BRIEF
February 26, 2001
- WORLD BUSINESS NEWS IN BRIEF
February 26, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 26, 2001
- New Law Specific for Medical Devices Is Necessary: JFITMA President
February 26, 2001
- Kirin to Sponsor Genomic Medical Engineering Course at Tottori Univ.
February 26, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…